TRACON Pharmaceuticals (NASDAQ:TCON – Get Rating) and Bavarian Nordic A/S (OTCMKTS:BVNRY – Get Rating) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation. Profitability This table compares TRACON Pharmaceuticals and Bavarian Nordic […]
StockNews.com began coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON – Get Rating) in a report published on Thursday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Several other research firms also recently weighed in on TCON. Robert W. Baird cut their price objective on TRACON Pharmaceuticals from $8.00 to $7.00 in a […]
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON – Get Rating) – HC Wainwright reduced their Q2 2023 EPS estimates for shares of TRACON Pharmaceuticals in a note issued to investors on Thursday, May 11th. HC Wainwright analyst E. White now expects that the biopharmaceutical company will earn ($0.36) per share for the quarter, down from their prior estimate […]
TRACON Pharmaceuticals (NASDAQ:TCON – Get Rating) had its price objective lowered by Robert W. Baird from $8.00 to $7.00 in a research report sent to investors on Thursday, The Fly reports. Several other research analysts have also issued reports on the stock. StockNews.com initiated coverage on shares of TRACON Pharmaceuticals in a research report on […]
TRACON Pharmaceuticals (NASDAQ:TCON – Get Rating) had its target price reduced by Maxim Group from $8.00 to $3.00 in a report published on Thursday morning, The Fly reports. Other equities analysts also recently issued research reports about the company. StockNews.com initiated coverage on TRACON Pharmaceuticals in a research report on Monday, May 1st. They set […]